MEI Pharma CEO Daniel Gold to depart, David Urso to succeed
- MEI Pharma (NASDAQ:MEIP) has announced that Daniel P. Gold, Ph.D’s tenure as the President and CEO of MEI will end on June 2, 2023 and the Co.’s board of directors has appointed David M. Urso as his successor.
- Mr. Urso, who joined the Co. in 2014 and has been serving as the Co.’s COO since 2018, will also join the board of directors.
- Dr. Gold will remain on MEI’s board, where he will continue to share his extensive knowledge and experience with the company.
- MEIP +5.43% premarket to $7.96.